Evidence map›Paper›PMID 38795807›Full record

ReviewCurrent problems in cardiology2024

Geographic proximity to cardiovascular clinical trial sites: A National analysis in the United States.

Pedro Rafael Vieira de Oliveira Salerno, Brendan Bourges-Sevenier, Zhuo Chen, Gabriel Tensol Rodrigues Pereira, Salil Deo, Khurram Nasir, Sanjay Rajagopalan, Sadeer Al-Kindi

Abstract readReview
In one paragraph

Review in Current problems in cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pedro Rafael Vieira de Oliveira SalernoHarrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.
Brendan Bourges-SevenierHarrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.
Zhuo ChenHarrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.
Gabriel Tensol Rodrigues PereiraHarrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.
Salil DeoSurgical Services, Louis Stokes VA Medical Center, Cleveland, OH, United States; Case Western Reserve University School of Medicine, Cleveland, OH, United States.
Khurram NasirHouston Methodist Hospital, Houston, TX, United States.
Sanjay RajagopalanHarrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, United States; Case Western Reserve University School of Medicine, Cleveland, OH, United States.
Sadeer Al-KindiHouston Methodist Hospital, Houston, TX, United States. Electronic address: sal-kindi@houstonmethodist.org.

Funding

ACHIEVE P3 - CHDP50MD017351 · NIMHD · WAYNE STATE UNIVERSITY · PI LANFEAR, DAVID E · 2021 to 2025
$21.1M
Diversity Suppplement (CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air PollutionR35ES031702 · NIEHS · CASE WESTERN RESERVE UNIVERSITY · PI Sanjay Rajagopalan · 2021 to 2026
$5.9M
NIEHS NIH HHS R35 ES031702NIMHD NIH HHS P50 MD017351
6 · The paper itself

Abstract

introductionSuboptimal geographical access to cardiovascular clinical trial sites (CV-CTS) may be a cause of inadequate demographic representation in contemporary trials. Thus, we investigate access to CV-CTS in the US.

methodsWe obtained the location of CV-CTS from Clinicaltrials.gov. We calculated the distance in kilometers from each ZIP code to the nearest CV-CTS, stratifying our results based on urban/rural setting, sex and race.

resultsWe identified a total of 10,506 studies in 4,630 US ZIP codes (10.5 %), of those only 237 (5 %) were rural. The overall median CV-CTS distance was 5.8 km (IQR: 2.7, 15.8). For urban residents, this distance was 4.5 km (IQR: 2.3, 9.2), while for rural residents, it was 24.2 km (IQR: 13.8, 42.2).

resultsWe revealed important disparities involving geographical proximity to cardiovascular clinical trial sites. Increasing the representation of these populations in clinical trials is paramount to improving the applicability of their findings to real-world settings.

Indexed as

Cardiovascular DiseasesClinical Trials as TopicRural PopulationUrban PopulationFemaleHealth Services AccessibilityHumansMaleUnited StatesCardiologyClinical trial sitesSocial and environmental determinants of health

Identifiers

PMID38795807
PMCPMC12046433

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.